1.99000 USD
0.05
2.58%
Last update Dec 16, 3:59 PM EST
Post-market
Day range
1.79000
2.060000
Previous close
1.94000
Open
1.90000
Access this stock data via API
Subscribe
Prelude Therapeutics Incorporated
1.99
0.05
2.58%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 7M 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 118.0M 103.4M 92.9M 86.8M
Selling general and admin 28.7M 28.9M 30.7M 27.0M
Other operating expenses
Operating income -139.7M -132.3M -123.5M -113.7M
Non operating interest income
Income
Expense
Other income expense 12.5M 10.4M 8.1M 2.0M
Pretax income -127.2M -121.8M -115.4M -111.7M
Tax provision
Net income -127.2M -121.8M -115.4M -111.7M
Basic EPS -1.7 -2.0 -2.4 -2.4
Diluted EPS -1.7 -2.0 -2.4 -2.4
Basic average shares 75.8M 60.4M 47.4M 46.0M
Diluted average shares 75.8M 60.4M 47.4M 46.0M
EBITDA -137.9M -131.1M -122.2M -112.8M
Net income from continuing op. -127.2M -121.8M -115.4M -111.7M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Post-market

Exchange is currently open for post-market.
Post market session closes in 39 minutes

19:21
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).